• Home
  • Pharmaceuticals and Healthcare
Postmenopausal Vaginal Atrophy (PVA) Treatment Market - Global Outlook and Forecast 2021-2027

Postmenopausal Vaginal Atrophy (PVA) Treatment Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687427 | No. of Pages: 100 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Postmenopausal Vaginal Atrophy (PVA) Treatment in Global, including the following market information:
Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Postmenopausal Vaginal Atrophy (PVA) Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Postmenopausal Vaginal Atrophy (PVA) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Segment Percentages, By Type, 2020 (%)
Systemic Estrogen Treatments
Non-estrogenic Therapies

China Postmenopausal Vaginal Atrophy (PVA) Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinics

Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Postmenopausal Vaginal Atrophy (PVA) Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Postmenopausal Vaginal Atrophy (PVA) Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
EndoCeutics
Upsher-Smith Laboratories
TherapeuticsMD
Bionovo
Pfizer
Novo Nordisk
Allergan
Shionogi
Ligand Pharmaceuticals
Bayer
Pantarhei Bioscience
Foamix Pharmaceuticals
Pep-Tonic Medical
Teva Pharmaceuticals
1 Introduction to Research & Analysis Reports
    1.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Overall Market Size
    2.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size: 2021 VS 2027
    2.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Postmenopausal Vaginal Atrophy (PVA) Treatment Players in Global Market
    3.2 Top Global Postmenopausal Vaginal Atrophy (PVA) Treatment Companies Ranked by Revenue
    3.3 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Postmenopausal Vaginal Atrophy (PVA) Treatment Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Postmenopausal Vaginal Atrophy (PVA) Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy (PVA) Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Postmenopausal Vaginal Atrophy (PVA) Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Postmenopausal Vaginal Atrophy (PVA) Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Markets, 2021 & 2027
        4.1.2 Systemic Estrogen Treatments
        4.1.3 Non-estrogenic Therapies
    4.2 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue & Forecasts
        4.2.1 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2021
        4.2.2 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2022-2027
        4.2.3 By Type - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Clinics
    5.2 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue & Forecasts
        5.2.1 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2021
        5.2.2 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2022-2027
        5.2.3 By Application - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2021 & 2027
    6.2 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue & Forecasts
        6.2.1 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2021
        6.2.2 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2022-2027
        6.2.3 By Region - Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2027
        6.3.2 US Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.3.3 Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.3.4 Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2027
        6.4.2 Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.4.3 France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.4.4 U.K. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.4.5 Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.4.6 Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.4.7 Nordic Countries Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.4.8 Benelux Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2027
        6.5.2 China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.5.3 Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.5.4 South Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.5.5 Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.5.6 India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2027
        6.6.2 Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.6.3 Argentina Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, 2016-2027
        6.7.2 Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.7.3 Israel Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.7.4 Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
        6.7.5 UAE Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size, 2016-2027
7 Players Profiles
    7.1 EndoCeutics
        7.1.1 EndoCeutics Corporate Summary
        7.1.2 EndoCeutics Business Overview
        7.1.3 EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.1.4 EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.1.5 EndoCeutics Key News
    7.2 Upsher-Smith Laboratories
        7.2.1 Upsher-Smith Laboratories Corporate Summary
        7.2.2 Upsher-Smith Laboratories Business Overview
        7.2.3 Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.2.4 Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.2.5 Upsher-Smith Laboratories Key News
    7.3 TherapeuticsMD
        7.3.1 TherapeuticsMD Corporate Summary
        7.3.2 TherapeuticsMD Business Overview
        7.3.3 TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.3.4 TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.3.5 TherapeuticsMD Key News
    7.4 Bionovo
        7.4.1 Bionovo Corporate Summary
        7.4.2 Bionovo Business Overview
        7.4.3 Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.4.4 Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.4.5 Bionovo Key News
    7.5 Pfizer
        7.5.1 Pfizer Corporate Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.5.4 Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.5.5 Pfizer Key News
    7.6 Novo Nordisk
        7.6.1 Novo Nordisk Corporate Summary
        7.6.2 Novo Nordisk Business Overview
        7.6.3 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.6.4 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.6.5 Novo Nordisk Key News
    7.7 Allergan
        7.7.1 Allergan Corporate Summary
        7.7.2 Allergan Business Overview
        7.7.3 Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.4.4 Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.7.5 Allergan Key News
    7.8 Shionogi
        7.8.1 Shionogi Corporate Summary
        7.8.2 Shionogi Business Overview
        7.8.3 Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.8.4 Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.8.5 Shionogi Key News
    7.9 Ligand Pharmaceuticals
        7.9.1 Ligand Pharmaceuticals Corporate Summary
        7.9.2 Ligand Pharmaceuticals Business Overview
        7.9.3 Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.9.4 Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.9.5 Ligand Pharmaceuticals Key News
    7.10 Bayer
        7.10.1 Bayer Corporate Summary
        7.10.2 Bayer Business Overview
        7.10.3 Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.10.4 Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.10.5 Bayer Key News
    7.11 Pantarhei Bioscience
        7.11.1 Pantarhei Bioscience Corporate Summary
        7.11.2 Pantarhei Bioscience Business Overview
        7.11.3 Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.11.4 Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.11.5 Pantarhei Bioscience Key News
    7.12 Foamix Pharmaceuticals
        7.12.1 Foamix Pharmaceuticals Corporate Summary
        7.12.2 Foamix Pharmaceuticals Business Overview
        7.12.3 Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.12.4 Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.12.5 Foamix Pharmaceuticals Key News
    7.13 Pep-Tonic Medical
        7.13.1 Pep-Tonic Medical Corporate Summary
        7.13.2 Pep-Tonic Medical Business Overview
        7.13.3 Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.13.4 Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.13.5 Pep-Tonic Medical Key News
    7.14 Teva Pharmaceuticals
        7.14.1 Teva Pharmaceuticals Corporate Summary
        7.14.2 Teva Pharmaceuticals Business Overview
        7.14.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Major Product Offerings
        7.14.4 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue in Global (2016-2021)
        7.14.5 Teva Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com